Protein arginine methylation in lymphocyte signaling

Current Opinion in Immunology
Fabien BlanchetOreste Acuto

Abstract

Methylation of arginine is an additional option within the repertoire of post-translational modifications that proteins utilize for their communication with other partner proteins and nucleic acids, which ultimately contributes to cellular functions. Recent studies reveal that protein arginine methylation is more common and widespread than previously thought and that it is implicated in a number of key cellular processes including signal transduction. Two recent investigations have propelled this new world of protein modification into the immunological community by showing that TCR and CD28 signaling exploit this pathway. In contrast to other protein modifications utilized in intracellular signaling, arginine methylation seems to be long-lasting, raising interesting questions as to when, where and for what reason it can be utilized in the lymphocyte differentiation processes.

References

Dec 13, 1996·Science·M R HodgeL H Glimcher
May 15, 1998·Trends in Biochemical Sciences·J M AlettaM J Ettinger
Jun 26, 1999·Science·D ChenM R Stallcup
May 8, 2002·The Journal of Experimental Medicine·Martin HoulardNadine Varin-Blank
Jul 3, 2002·Nature Reviews. Immunology·Martin Turner, Daniel D Billadeau
Oct 11, 2002·The EMBO Journal·Martine Chevillard-BrietLaurence Vandel
May 21, 2003·Proceedings of the National Academy of Sciences of the United States of America·Neelu YadavMark T Bedford
Jul 23, 2003·Molecular & Cellular Proteomics : MCP·Jonathan E KatzSteven Clarke
Oct 10, 2003·Molecular & Cellular Proteomics : MCP·François-Michel BoisvertStéphane Richard
Dec 4, 2003·Nature Reviews. Immunology·Oreste Acuto, Frédérique Michel
Apr 2, 2004·The Journal of Biological Chemistry·Donghang ChengMark T Bedford
Aug 26, 2004·Molecular Cell·Kerri A MowenLaurie H Glimcher
Sep 2, 2004·Cell·Graeme L CuthbertTony Kouzarides
Dec 15, 2004·Journal of Virology·Marie-Chloé BoulangerStéphane Richard
Dec 29, 2004·Cell·Stefan Kubicek, Thomas Jenuwein
Mar 23, 2005·Nature Methods·Shao-En OngMatthias Mann
Apr 14, 2005·The Journal of Biological Chemistry·Waraporn KomyodIris Behrmann
Jun 16, 2005·The Journal of Biological Chemistry·Jocelyn Côté, Stéphane Richard
Jul 30, 2005·The Journal of Biological Chemistry·Jaeho LeeMark T Bedford
Aug 3, 2005·The Journal of Experimental Medicine·Fabien BlanchetOreste Acuto
Sep 15, 2005·Biochemical and Biophysical Research Communications·Tina Branscombe MirandaSteven Clarke

❮ Previous
Next ❯

Citations

Mar 17, 2010·The Journal of Experimental Medicine·Simona InfantinoMichael Reth
Jun 21, 2011·Eukaryotic Cell·John C Fisk, Laurie K Read
Dec 4, 2012·International Journal of Molecular Sciences·Dariusz ZakrzewiczMalgorzata Wygrecka
Nov 23, 2006·FEBS Letters·Masako InamitsuMitsuyasu Kato
Jan 21, 2016·Expert Opinion on Investigational Drugs·Hao HuY George Zheng
Apr 16, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Virginie TardifBrian R Lawson
Mar 1, 2012·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Brian R LawsonArgyrios N Theofilopoulos
May 19, 2016·Immunity·Jonathan H EsenstenJeffrey A Bluestone
Sep 14, 2016·Oncoimmunology·Frederik C HenrichAndreas Mackensen
Oct 14, 2017·Nature Communications·Simona InfantinoDavid Tarlinton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.